ReviewIranian journal of public health2025
The Acceptability of Implanon in Muslim-Majority Asian Countries: A Systematic Review.
Review in Iranian journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- How painful is Implanon NXTBMC women's health · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We conducted a systematic review which aimed to assess acceptability of implanon used based on reported side effects, continuation rates and user satisfaction in Muslim-majority Asian countries. Methods: We followed PRISMA guideline and searched SCOPUS and Medline databases for original articles that dealt with implanon, conducted in Muslim-majority Asian countries and had either continuation rates or side effects or satisfaction rate. The risk of bias of the selected studies was assessed using ROBINS-I V2 Risk of Bias tool. Results: The literature search successfully identified 7 potentially relevant articles, whereby 5 of them met the inclusion criteria. 5 articles were retained in the final synthesis with 619 total participants. Implanon's documented side effects such as menstrual irregularity and weight gain, is tolerable due to its high efficacy. Implanon has low discontinuation rates among users and has a high satisfaction rate. Conclusion: Implanon is widely accepted in Muslim-majority Asian countries with a positive impact on family planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.